Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Efficient Transmission of Mixed Plasmodium falciparum/vivax Infections From Humans to Mosquitoes.

Balasubramanian S, Rahman RS, Lon C, Parobek C, Ubalee R, Hathaway N, Kuntawunginn W, My M, Vy D, Saxe J, Lanteri C, Lin FC, Spring M, Meshnick SR, Juliano JJ, Saunders DL, Lin JT.

J Infect Dis. 2020 Jan 14;221(3):428-437. doi: 10.1093/infdis/jiz388.

PMID:
31549156
2.

Evolution of the Leaf Expander: A Maxillary Self Expander.

Beretta M, Lanteri C, Lanteri V, Cherchi C, Franchi L, Gianolio A.

J Clin Orthod. 2019;53(5):260-266. No abstract available.

PMID:
31393845
3.

Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation.

Ross J, McMurray K, Cameron T, Lanteri C.

OTO Open. 2019 Mar 22;3(1):2473974X19836432. doi: 10.1177/2473974X19836432. eCollection 2019 Jan-Mar.

4.

Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR).

Lanteri C, Mende K, Kortepeter M.

Mil Med. 2019 Nov 1;184(Supplement_2):59-65. doi: 10.1093/milmed/usz081.

PMID:
31004432
5.

Three-dimensional evaluation of rapid maxillary expansion anchored to primary molars: direct effects on maxillary arch and spontaneous mandibular response.

Di Ventura A, Lanteri V, Farronato G, Gaffuri F, Beretta M, Lanteri C, Cossellu G.

Eur J Paediatr Dent. 2019 Mar;20(1):38-42. doi: 10.23804/ejpd.2019.20.01.08.

6.

Comparison between RME, SME and Leaf Expander in growing patients: a retrospective postero-anterior cephalometric study.

Lanteri V, Cossellu G, Gianolio A, Beretta M, Lanteri C, Cherchi C, Farronato G.

Eur J Paediatr Dent. 2018 Sep;19(3):199-204. doi: 10.23804/ejpd.2018.19.03.06.

7.

The efficacy of orthodontic treatments for anterior crowding with Invisalign compared with fixed appliances using the Peer Assessment Rating Index.

Lanteri V, Farronato G, Lanteri C, Caravita R, Cossellu G.

Quintessence Int. 2018;49(7):581-587. doi: 10.3290/j.qi.a40511.

PMID:
29881831
8.

Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.

Chaorattanakawee S, Lon C, Chann S, Thay KH, Kong N, You Y, Sundrakes S, Thamnurak C, Chattrakarn S, Praditpol C, Yingyuen K, Wojnarski M, Huy R, Spring MD, Walsh DS, Patel JC, Lin J, Juliano JJ, Lanteri CA, Saunders DL.

Malar J. 2017 Sep 30;16(1):392. doi: 10.1186/s12936-017-2034-2.

9.

Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.

Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, Shetty AC, Drabek EF, Jacob CG, Henrich PP, Parobek CM, Jongsakul K, Huy R, Spring MD, Lanteri CA, Chaorattanakawee S, Lon C, Fukuda MM, Saunders DL, Fidock DA, Lin JT, Juliano JJ, Plowe CV, Silva JC, Takala-Harrison S.

J Infect Dis. 2017 Aug 15;216(4):468-476. doi: 10.1093/infdis/jix334.

10.

Utility of the Nanosphere Verigene in the Identification of Bacteremia Isolates From the Burn Intensive Care Unit.

Farmer A, Lanteri CA, Steele E, Mende K, Pamplin J, Akers KS.

Mil Med. 2017 Sep;182(9):e1779-e1784. doi: 10.7205/MILMED-D-17-00018.

PMID:
28885937
11.

Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.

Parobek CM, Parr JB, Brazeau NF, Lon C, Chaorattanakawee S, Gosi P, Barnett EJ, Norris LD, Meshnick SR, Spring MD, Lanteri CA, Bailey JA, Saunders DL, Lin JT, Juliano JJ.

Genome Biol Evol. 2017 Jun 1;9(6):1673-1686. doi: 10.1093/gbe/evx126.

12.

Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.

Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, Kuntawunginn W, My M, Thay K, Rahman R, Balasubramanian S, Char M, Lanteri CA, Gosi P, Ubalee R, Meshnick SR, Saunders DL.

PLoS One. 2017 Jun 7;12(6):e0168702. doi: 10.1371/journal.pone.0168702. eCollection 2017.

13.

Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.

Vanachayangkul P, Lon C, Spring M, Sok S, Ta-Aksorn W, Kodchakorn C, Pann ST, Chann S, Ittiverakul M, Sriwichai S, Buathong N, Kuntawunginn W, So M, Youdaline T, Milner E, Wojnarski M, Lanteri C, Manning J, Prom S, Haigney M, Cantilena L, Saunders D.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02000-16. doi: 10.1128/AAC.02000-16. Print 2017 May.

14.

Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia.

Parobek CM, Lin JT, Saunders DL, Barnett EJ, Lon C, Lanteri CA, Balasubramanian S, Brazeau N, DeConti DK, Garba DL, Meshnick SR, Spring MD, Chuor CM, Bailey JA, Juliano JJ.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8096-E8105. Epub 2016 Nov 28.

15.

The Leaf Expander for Non-Compliance Treatment in the Mixed Dentition.

Lanteri C, Beretta M, Lanteri V, Gianolio A, Cherchi C, Franchi L.

J Clin Orthod. 2016 Sep;50(9):552-560. No abstract available.

PMID:
27809214
16.

Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.

Chaorattanakawee S, Lon C, Jongsakul K, Gawee J, Sok S, Sundrakes S, Kong N, Thamnurak C, Chann S, Chattrakarn S, Praditpol C, Buathong N, Uthaimongkol N, Smith P, Sirisopana N, Huy R, Prom S, Fukuda MM, Bethell D, Walsh DS, Lanteri C, Saunders D.

Malar J. 2016 Oct 21;15(1):519.

17.

Genetic diversity among Plasmodium vivax isolates along the Thai-Myanmar border of Thailand.

Maneerattanasak S, Gosi P, Krudsood S, Tongshoob J, Lanteri CA, Snounou G, Khusmith S.

Malar J. 2016 Feb 9;15:75. doi: 10.1186/s12936-016-1136-6.

18.

Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.

Saunders DL, Chaorattanakawee S, Gosi P, Lanteri C, Somethy S, Kuntawunginn W, Ittiverakul M, Chann S, Gregory C, Chuor CM, Prom S, Spring MD, Lon C.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1896-8. doi: 10.1128/AAC.02302-15.

19.

Microscopic Plasmodium falciparum Gametocytemia and Infectivity to Mosquitoes in Cambodia.

Lin JT, Ubalee R, Lon C, Balasubramanian S, Kuntawunginn W, Rahman R, Saingam P, Heng TK, Vy D, San S, Nuom S, Burkly H, Chanarat N, Ponsa C, Levitz L, Parobek C, Chuor CM, Somethy S, Spring M, Lanteri C, Gosi P, Meshnick SR, Saunders DL.

J Infect Dis. 2016 May 1;213(9):1491-4. doi: 10.1093/infdis/jiv599. Epub 2015 Dec 13.

20.

Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.

Chaorattanakawee S, Lanteri CA, Sundrakes S, Yingyuen K, Gosi P, Chanarat N, Wongarunkochakorn S, Buathong N, Chann S, Kuntawunginn W, Arsanok M, Lin JT, Juliano JJ, Tyner SD, Char M, Lon C, Saunders DL.

Malar J. 2015 Dec 2;14:486. doi: 10.1186/s12936-015-1021-8.

21.

Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.

Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, Saingam P, Buathong N, Sriwichai S, Chann S, Se Y, Yom Y, Heng TK, Kong N, Kuntawunginn W, Tangthongchaiwiriya K, Jacob C, Takala-Harrison S, Plowe C, Lin JT, Chuor CM, Prom S, Tyner SD, Gosi P, Teja-Isavadharm P, Lon C, Lanteri CA.

Antimicrob Agents Chemother. 2015 Aug;59(8):4631-43. doi: 10.1128/AAC.00366-15. Epub 2015 May 26.

22.

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.

Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-ngam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, Ta-aksorn W, Chanarat N, Sundrakes S, Kong N, Heng TK, Nou S, Teja-isavadharm P, Pichyangkul S, Phann ST, Balasubramanian S, Juliano JJ, Meshnick SR, Chour CM, Prom S, Lanteri CA, Lon C, Saunders DL.

Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.

PMID:
25877962
23.

Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.

Lin JT, Hathaway NJ, Saunders DL, Lon C, Balasubramanian S, Kharabora O, Gosi P, Sriwichai S, Kartchner L, Chuor CM, Satharath P, Lanteri C, Bailey JA, Juliano JJ.

J Infect Dis. 2015 Sep 15;212(6):999-1008. doi: 10.1093/infdis/jiv142. Epub 2015 Mar 6.

24.

Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).

Saunders D, Vanachayangkul P, Imerbsin R, Khemawoot P, Siripokasupkul R, Tekwani BL, Sampath A, Nanayakkara NP, Ohrt C, Lanteri C, Gettyacamin M, Teja-Isavadharm P, Walker L.

Antimicrob Agents Chemother. 2014 Dec;58(12):7283-91. doi: 10.1128/AAC.02576-13. Epub 2014 Sep 29.

25.

Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.

Manning J, Vanachayangkul P, Lon C, Spring M, So M, Sea D, Se Y, Somethy S, Phann ST, Chann S, Sriwichai S, Buathong N, Kuntawunginn W, Mitprasat M, Siripokasupkul R, Teja-Isavadharm P, Soh E, Timmermans A, Lanteri C, Kaewkungwal J, Auayporn M, Tang D, Chour CM, Prom S, Haigney M, Cantilena L, Saunders D.

Antimicrob Agents Chemother. 2014 Oct;58(10):6056-67. doi: 10.1128/AAC.02667-14. Epub 2014 Aug 4.

26.

Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.

Lanteri CA, Chaorattanakawee S, Lon C, Saunders DL, Rutvisuttinunt W, Yingyuen K, Bathurst I, Ding XC, Tyner SD.

Antimicrob Agents Chemother. 2014 Oct;58(10):5831-40. doi: 10.1128/AAC.02462-14. Epub 2014 Jul 21.

27.

Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.

Lon C, Manning JE, Vanachayangkul P, So M, Sea D, Se Y, Gosi P, Lanteri C, Chaorattanakawee S, Sriwichai S, Chann S, Kuntawunginn W, Buathong N, Nou S, Walsh DS, Tyner SD, Juliano JJ, Lin J, Spring M, Bethell D, Kaewkungwal J, Tang D, Chuor CM, Satharath P, Saunders D.

PLoS One. 2014 Mar 25;9(3):e93138. doi: 10.1371/journal.pone.0093138. eCollection 2014.

28.

Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine.

Lon C, Spring M, Sok S, Chann S, Bun R, Ittiverakul M, Buathong N, Thay K, Kong N, You Y, Kuntawunginn W, Lanteri CA, Saunders DL.

Malar J. 2014 Mar 14;13:96. doi: 10.1186/1475-2875-13-96.

29.

Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.

Gosi P, Lanteri CA, Tyner SD, Se Y, Lon C, Spring M, Char M, Sea D, Sriwichai S, Surasri S, Wongarunkochakorn S, Pidtana K, Walsh DS, Fukuda MM, Manning J, Saunders DL, Bethell D.

Malar J. 2013 Nov 9;12:403. doi: 10.1186/1475-2875-12-403.

30.

Development of a capillary electrophoresis-based heteroduplex tracking assay to measure in-host genetic diversity of initial and recurrent Plasmodium vivax infections in Cambodia.

Givens MB, Lin JT, Lon C, Gosi P, Char MC, Lanteri CA, Saunders DL, Juliano JJ.

J Clin Microbiol. 2014 Jan;52(1):298-301. doi: 10.1128/JCM.02274-13. Epub 2013 Oct 16.

31.

Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons.

Lanteri C, Doucet EL, Hernández Vallejo SJ, Godeheu G, Bobadilla AC, Salomon L, Lanfumey L, Tassin JP.

Mol Psychiatry. 2014 Jul;19(7):823-33. doi: 10.1038/mp.2013.97. Epub 2013 Aug 20.

PMID:
23958955
32.

Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.

Chaorattanakawee S, Tyner SD, Lon C, Yingyuen K, Ruttvisutinunt W, Sundrakes S, Sai-gnam P, Johnson JD, Walsh DS, Saunders DL, Lanteri CA.

Malar J. 2013 Jul 12;12:239. doi: 10.1186/1475-2875-12-239.

33.

Sustained impairment of α2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine.

Doucet EL, Bobadilla AC, Houades V, Lanteri C, Godeheu G, Lanfumey L, Sara SJ, Tassin JP.

Biol Psychiatry. 2013 Jul 15;74(2):90-8. doi: 10.1016/j.biopsych.2012.11.029. Epub 2013 Jan 17.

PMID:
23332355
34.

Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons.

Barik J, Marti F, Morel C, Fernandez SP, Lanteri C, Godeheu G, Tassin JP, Mombereau C, Faure P, Tronche F.

Science. 2013 Jan 18;339(6117):332-5. doi: 10.1126/science.1226767.

35.

Dentoskeletal effects of the fast-back molar distalizer followed by fixed appliances.

Buongiorno M, Iacopetti F, Beretta M, Lanteri C, Defraia E.

Prog Orthod. 2012 Nov;13(3):218-25. doi: 10.1016/j.pio.2012.03.004. Epub 2012 Jun 27.

PMID:
23260532
36.

Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice.

Dow GS, Milner E, Bathurst I, Bhonsle J, Caridha D, Gardner S, Gerena L, Kozar M, Lanteri C, Mannila A, McCalmont W, Moon J, Read KD, Norval S, Roncal N, Shackleford DM, Sousa J, Steuten J, White KL, Zeng Q, Charman SA.

Malar J. 2011 Jun 6;10:150. doi: 10.1186/1475-2875-10-150.

37.

Maxillary molar distalization: Pendulum and Fast-Back, comparison between two approaches for Class II malocclusion.

Caprioglio A, Beretta M, Lanteri C.

Prog Orthod. 2011;12(1):8-16. doi: 10.1016/j.pio.2011.02.007. Epub 2011 Mar 31.

PMID:
21515227
38.

A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.

Opsenica I, Burnett JC, Gussio R, Opsenica D, Todorović N, Lanteri CA, Sciotti RJ, Gettayacamin M, Basilico N, Taramelli D, Nuss JE, Wanner L, Panchal RG, Solaja BA, Bavari S.

J Med Chem. 2011 Mar 10;54(5):1157-69. doi: 10.1021/jm100938u. Epub 2011 Jan 25.

39.

Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance.

Hughes LM, Lanteri CA, O'Neil MT, Johnson JD, Gribble GW, Trumpower BL.

Mol Biochem Parasitol. 2011 May;177(1):12-9. doi: 10.1016/j.molbiopara.2011.01.002. Epub 2011 Jan 18.

40.

Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols.

Milner E, McCalmont W, Bhonsle J, Caridha D, Cobar J, Gardner S, Gerena L, Goodine D, Lanteri C, Melendez V, Roncal N, Sousa J, Wipf P, Dow GS.

Malar J. 2010 Feb 11;9:51. doi: 10.1186/1475-2875-9-51.

41.

Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum.

Milner E, McCalmont W, Bhonsle J, Caridha D, Carroll D, Gardner S, Gerena L, Gettayacamin M, Lanteri C, Luong T, Melendez V, Moon J, Roncal N, Sousa J, Tungtaeng A, Wipf P, Dow G.

Bioorg Med Chem Lett. 2010 Feb 15;20(4):1347-51. doi: 10.1016/j.bmcl.2010.01.001. Epub 2010 Jan 7.

PMID:
20097070
42.

Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.

Lanteri C, Hernández Vallejo SJ, Salomon L, Doucet EL, Godeheu G, Torrens Y, Houades V, Tassin JP.

J Neurosci. 2009 Jan 28;29(4):987-97. doi: 10.1523/JNEUROSCI.3315-08.2009.

43.

New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.

Opsenica I, Opsenica D, Lanteri CA, Anova L, Milhous WK, Smith KS, Solaja BA.

J Med Chem. 2008 Oct 9;51(19):6216-9. doi: 10.1021/jm8006905. Epub 2008 Sep 6.

PMID:
18774792
44.

Recent advances in malaria drug discovery.

Lanteri CA, Johnson JD, Waters NC.

Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):95-114. Review.

PMID:
18221166
45.

The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.

Lanteri CA, Tidwell RR, Meshnick SR.

Antimicrob Agents Chemother. 2008 Mar;52(3):875-82. Epub 2007 Dec 17.

46.

Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism.

Lanteri C, Salomon L, Torrens Y, Glowinski J, Tassin JP.

Neuropsychopharmacology. 2008 Jun;33(7):1724-34. Epub 2007 Sep 5.

47.

Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors.

Salomon L, Lanteri C, Godeheu G, Blanc G, Gingrich J, Tassin JP.

Psychopharmacology (Berl). 2007 Sep;194(1):11-20. Epub 2007 May 19.

PMID:
17510759
48.

Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive mice.

Tassin JP, Torrens Y, Salomon L, Lanteri C, Seeman P.

Synapse. 2007 Jul;61(7):569-72.

PMID:
17447259
49.

[Uncoupling between noradrenergic and serotonergic neurons: As a mechanism for drug addiction].

Tassin JP, Lanteri C, Salomon L.

Med Sci (Paris). 2006 Oct;22(10):798-800. French. No abstract available.

50.

Utility of alkylaminoquinolinyl methanols as new antimalarial drugs.

Dow GS, Heady TN, Bhattacharjee AK, Caridha D, Gerena L, Gettayacamin M, Lanteri CA, Obaldia N 3rd, Roncal N, Shearer T, Smith PL, Tungtaeng A, Wolf L, Cabezas M, Yourick D, Smith KS.

Antimicrob Agents Chemother. 2006 Dec;50(12):4132-43. Epub 2006 Sep 11.

Supplemental Content

Loading ...
Support Center